Overview

Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia

Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
0
Participant gender:
Male
Summary
The purpose of this study is to evaluate the efficacy of Finlândia hair lotion association in the treatment of androgenetic alopecia.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
EMS
Treatments:
Finasteride
Minoxidil
Criteria
Inclusion Criteria:

- Ability to confirm voluntary participation and agree to all trial purposes by signing
and dating the informed consent forms;

- Men aged 18 years or over and less than or equal to 60 years with a diagnosis of
Androgenetic Alopecia grades IIIv to IV in the modified Norwood-Hamilton
classification, who have been using minoxidil 5% for at least 3 months and willing to
maintain the same style, approximate length and hair color throughout the test.

Exclusion Criteria:

- Known hypersensitivity to the formula components used during the clinical trial;

- History of alcohol and/or substance abuse within 2 years;

- Participants with other concomitant dermatological diseases on the scalp, except for
mild seborrhoea dermatitis;

- Participants with a history of surgical treatment for hair loss or shaved scalp;

- Participants who used shampoo or topical solution containing ketoconazole, tar,
selenium, threonine or steroids in the last 2 weeks;

- Participants who used 5α reductase inhibitors, such as finasteride and dutasteride, in
the last 12 months;

- Participants using testosterone replacement therapy (TRT) or using
testosterone-containing gel;

- Participants who used micro-infusion of medications on the skin (MMP), microneedling
or intradermotherapy on the scalp in the last 3 months;

- Participants who have undergone radiation treatment for the scalp or chemotherapy in
the past year;

- Participants with diseases that can affect hair growth;

- Participants with a current medical history of cancer and / or cancer treatment in the
last 5 years;